Header Logo

Connection

Christopher Hemond to Alemtuzumab

Back to Details
This is a "connection" page, showing publications Christopher Hemond has written about Alemtuzumab.
Christopher Hemond
Connection Strength
0.176
Alemtuzumab
  1. Herman JA, Khalighinejad F, York K, Radu I, Berrios Morales I, Ionete C, Hemond CC. A real-world cohort analysis of alemtuzumab outcomes in relapsing multiple sclerosis. Mult Scler Relat Disord. 2021 Jan; 47:102619.
    View in: PubMed
    Score: 0.176
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.